Do elevated sarcosine and methionine reflect altered methyl group movement?

Biochemical mechanisms of methyl flux

• The GNMT metabolic buffer: Glycine N-methyltransferase (GNMT) serves as a critical metabolic "rheostat" or buffer in mammalian tissues. It catalyzes a single-step bimolecular nucleophilic substitution ($S_N2$) reaction, transferring a methyl group from S-adenosyl-L-methionine (SAM) to the amino group of glycine, yielding sarcosine (N-methylglycine) and S-adenosylhomocysteine (SAH).
• High-capacity buffering: Unlike other methyltransferases, GNMT has a relatively low affinity for SAM and is poorly inhibited by its product, SAH. This unique kinetic profile allows GNMT to act as a metabolic safety valve, consuming excess SAM when levels rise to maintain the critical SAM/SAH ratio and protect the cell from aberrant hypermethylation.
• Precursor dynamics: Methionine is the direct upstream precursor to SAM, with its conversion catalyzed by methionine adenosyltransferase (MAT). Because intracellular SAM concentrations and the Michaelis constants ($K_m$) of major DNA and histone methyltransferases (such as DNMT3A [$K_m \approx 0.2\text{–}2.56\ \mu\text{M}$] and G9a [$K_m \approx 0.53\ \mu\text{M}$]) fall within comparable micromolar ranges, fluctuations in methionine directly dictate global transmethylation rates.

Clinical and metabolic implications

• Markers of methyl group movement: Combined elevations in methionine and sarcosine serve as highly sensitive, coordinated indicators of accelerated methyl group movement and high SAM turnover.
• Epigenetic consequences: Elevated sarcosine can increase the cellular methylation potential (SAM/SAH ratio) and drive global DNA and CpG island hypermethylation. Conversely, while methionine loading initially fuels SAM-dependent methylation, excessive accumulation or downstream bottlenecks can lead to SAH buildup, lowering the SAM/SAH ratio and paradoxically triggering global hypomethylation.
• Tissue-specific sensitivity: The impact of altered methionine flux is highly tissue-dependent. For example, dietary methionine restriction in animal models lowers SAH in the liver (preserving global DNA methylation) but elevates SAH in adipose tissue, leading to hypomethylation.

Bottom line

Elevated sarcosine and methionine directly reflect altered methyl group movement through the glycine and methionine pathways. Methionine fuels the synthesis of SAM, while GNMT acts as a metabolic safety valve, converting excess SAM into sarcosine to buffer cellular methylation potential and regulate epigenetic stability.